Here are 5 anti-obesity drug stocks besides Novo Nordisk and Eli Lilly to watch into year-end – CNBC October 29, 2023
Novo Nordisk snaps up Inversago Pharma for up to $1B+ on the back of megablockbuster Wegovy sales – Endpoints News August 10, 2023
As Novo Nordisk begins PhII sickle cell trial, it snags a later-stage blood disorder drug in $1.1B Forma buy – Endpoints News September 1, 2022September 1, 2022
Novo Nordisk’s blockbuster diabetes drug blows the doors off in obesity, proving highly effective in driving weight loss – Endpoints News February 11, 2021February 11, 2021